Torchilin V - Search Results

1

Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG.

Pattni BS, Jhaveri A, Dutta I, Baleja JD, Degterev A, Torchilin V. Pattni BS, et al. Among authors: torchilin v. Int J Pharm. 2017 Oct 30;532(1):149-156. doi: 10.1016/j.ijpharm.2017.08.095. Epub 2017 Aug 24. Int J Pharm. 2017. PMID: 28844900 Free PMC article.

2

Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.

Riehle R, Pattni B, Jhaveri A, Kulkarni A, Thakur G, Degterev A, Torchilin V. Riehle R, et al. Among authors: torchilin v. Pharm Res. 2016 Jul;33(7):1587-601. doi: 10.1007/s11095-016-1899-z. Epub 2016 Mar 7. Pharm Res. 2016. PMID: 26951567

3

Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.

Jhaveri A, Deshpande P, Pattni B, Torchilin V. Jhaveri A, et al. Among authors: torchilin v. J Control Release. 2018 May 10;277:89-101. doi: 10.1016/j.jconrel.2018.03.006. Epub 2018 Mar 6. J Control Release. 2018. PMID: 29522834 Free PMC article.

4

Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.

Pattni BS, Nagelli SG, Aryasomayajula B, Deshpande PP, Kulkarni A, Hartner WC, Thakur G, Degterev A, Torchilin VP. Pattni BS, et al. Pharm Res. 2016 Oct;33(10):2540-51. doi: 10.1007/s11095-016-1978-1. Epub 2016 Jun 28. Pharm Res. 2016. PMID: 27351426 Free PMC article.

5

Micellar formulations of pro-apoptotic DM-PIT-1 analogs and TRAIL in vitro and in vivo.

Riehle RD, Cornea S, Degterev A, Torchilin V. Riehle RD, et al. Among authors: torchilin v. Drug Deliv. 2013 Feb;20(2):78-85. doi: 10.3109/10717544.2013.766780. Epub 2013 Mar 16. Drug Deliv. 2013. PMID: 23495715 Free article.

6

Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro.

Sriraman SK, Geraldo V, Luther E, Degterev A, Torchilin V. Sriraman SK, et al. Among authors: torchilin v. J Control Release. 2015 Dec 28;220(Pt A):160-168. doi: 10.1016/j.jconrel.2015.10.037. Epub 2015 Oct 21. J Control Release. 2015. PMID: 26497930 Free PMC article.

7

Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.

Deshpande P, Jhaveri A, Pattni B, Biswas S, Torchilin V. Deshpande P, et al. Among authors: torchilin v. Drug Deliv. 2018 Nov;25(1):517-532. doi: 10.1080/10717544.2018.1435747. Drug Deliv. 2018. PMID: 29433357 Free PMC article.

8

The effect of transferrin-targeted, resveratrol-loaded liposomes on neurosphere cultures of glioblastoma: implications for targeting tumour-initiating cells.

Jhaveri A, Luther E, Torchilin V. Jhaveri A, et al. Among authors: torchilin v. J Drug Target. 2019 Jun-Jul;27(5-6):601-613. doi: 10.1080/1061186X.2018.1550647. Epub 2018 Dec 4. J Drug Target. 2019. PMID: 30475084

9

Intracellular delivery of nanocarriers and targeting to subcellular organelles.

Jhaveri A, Torchilin V. Jhaveri A, et al. Among authors: torchilin v. Expert Opin Drug Deliv. 2016;13(1):49-70. doi: 10.1517/17425247.2015.1086745. Epub 2015 Sep 11. Expert Opin Drug Deliv. 2016. PMID: 26358656 Review.

10

Stimuli-sensitive nanopreparations for combination cancer therapy.

Jhaveri A, Deshpande P, Torchilin V. Jhaveri A, et al. Among authors: torchilin v. J Control Release. 2014 Sep 28;190:352-70. doi: 10.1016/j.jconrel.2014.05.002. Epub 2014 May 10. J Control Release. 2014. PMID: 24818767 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

538 results

Search Page

Filters